DEREK JAY: Open Payments
NPI 1427819721 · NEW BREMEN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 37 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $97 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $181 |
| AstraZeneca Pharmaceuticals LP | 7 | $137 |
| ABBVIE INC. | 5 | $91 |
| Abbott Laboratories | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Exact Sciences Corporation | 2 | $36 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: NURTEC ODT, AIRSUPRA, QULIPTA, ELIQUIS, FARXIGA, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, TRUMENBA.
Industry payments across OH — which companies pay providers there.
